DIPEXIUM PHARMACEUTICALS INC's ticker is DPRX and the CUSIP is 25456J104. A total of 27 filers reported holding DIPEXIUM PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $1,186,000 | +86.8% | 81,815 | +27.6% | 0.47% | +75.5% |
| Q2 2016 | $635,000 | +51.6% | 64,124 | +45.4% | 0.27% | +52.0% |
| Q1 2016 | $419,000 | -60.9% | 44,110 | -53.9% | 0.18% | -59.3% |
| Q4 2015 | $1,071,000 | -43.2% | 95,647 | -29.0% | 0.44% | -42.8% |
| Q3 2015 | $1,886,000 | -20.5% | 134,716 | -27.7% | 0.76% | +10.8% |
| Q2 2015 | $2,372,000 | +1.3% | 186,453 | +8.6% | 0.69% | -1.6% |
| Q1 2015 | $2,341,000 | +37.7% | 171,638 | +14.9% | 0.70% | +4.5% |
| Q4 2014 | $1,700,000 | +19.7% | 149,340 | +4.6% | 0.67% | +2.9% |
| Q3 2014 | $1,420,000 | +7.8% | 142,724 | +5.1% | 0.65% | +9.8% |
| Q2 2014 | $1,317,000 | -12.9% | 135,740 | -9.5% | 0.59% | -26.1% |
| Q1 2014 | $1,512,000 | – | 150,000 | – | 0.80% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lone Star Value Management LLC | 95,000 | $1,330,000 | 2.54% |
| Timpani Capital Management LLC | 134,716 | $1,886,000 | 0.76% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 981,100 | $13,735,000 | 0.66% |
| 1492 Capital Management LLC | 38,000 | $532,000 | 0.38% |
| Broadfin Capital, LLC | 465,978 | $6,524,000 | 0.36% |
| Tourbillon Capital Partners, L.P. | 785,615 | $10,999,000 | 0.29% |
| ARDSLEY ADVISORY PARTNERS LP | 45,000 | $630,000 | 0.15% |
| 683 Capital Management, LLC | 70,000 | $980,000 | 0.14% |
| BOOTHBAY FUND MANAGEMENT, LLC | 18,043 | $253,000 | 0.12% |
| FALCON POINT CAPITAL, LLC | 22,570 | $316,000 | 0.11% |